Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Cardiovascular Abnormalities: early-phase trial registry

2 of 6 indexed Cardiovascular Abnormalities trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 2 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Cardiovascular Abnormalities: 6 US clinical trials tracked, 2 recruiting.

Cardiovascular Abnormalities is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is atHeart Medical, running 1 of these trials.

Enrollment posture brief

Registry condition cardiovascular-abnormalities

OPEN 2 | RECR 33% | LATE 0 | EARLY 3 | RANK #2866 | SPON 1

Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Cardiovascular Abnormali (th…33%
Open-enrollment share among volume-matched conditions near Cardiovascular Abnormalities

Cardiovascular Abnormalities lists 2 open slots (33% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cardiovascular Abnormalities on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cardiovascular Abnormalities is recruiting below its size-band peers.

    2 of 6 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Cardiovascular Abnormalities research.

    atHeart Medical accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Typical Cardiovascular Abnormalities enrolment sits around 150 participants.

    Median target enrolment is 150 among the 6 trials that report a genuine target (sentinel values excluded). 2 of those (33.3%) plan for fewer than 100 participants.

  4. Cardiovascular Abnormalities splits between interventional and observational designs.

    4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 22

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 2

Named interventions

Most-linked intervention names on Cardiovascular Abnormalities records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

reSept ASD Occluder Device
1 trials
Tissue Engineered Vascular Grafts Combination
1 trials
Mirtazapine Drug
1 trials
Methamphetamine Drug
1 trials
Carvedilol Drug
1 trials

US sites by state

Facility locations filed on Cardiovascular Abnormalities trials. A trial with sites in several states counts in each.

Ohio 2 trials
New York 2 trials
Illinois 2 trials
California 2 trials
Texas 1 trials
South Carolina 1 trials
Pennsylvania 1 trials
Missouri 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Cardiovascular Abnormalities page

6 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 2 Cardiovascular Abnormalities trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • atHeart Medical sponsors the most Cardiovascular Abnormalities trials on record, review their full trial history before evaluating a specific study. See atHeart Medical's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cardiovascular Abnormalities condition card totals 6 registered trials; most-linked intervention reSept ASD Occluder; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.